13.64 USD
+0.25 (+1.87%)
13.74 USD
+0.1 (+0.73%)
ChartMill assigns a Buy % Consensus number of 84% to MNMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 26.15. This target is 91.71% above the current price.
MNMD was analyzed by 18 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about MNMD.
In the previous month the buy percentage consensus was at a similar level.
MNMD was analyzed by 18 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-23 | Jones Trading | Initiate | Buy |
| 2025-11-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-11-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-10-13 | Needham | Initiate | Buy |
| 2025-08-04 | Oppenheimer | Reiterate | Outperform |
| 2025-08-01 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-07 | Baird | Maintains | Outperform -> Outperform |
| 2025-03-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-28 | Evercore ISI Group | Initiate | Outperform |
| 2024-12-20 | Chardan Capital | Initiate | Buy |
| 2024-12-17 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-07-31 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-24 | Roth MKM | Maintains | Buy -> Buy |
| 2024-06-21 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-28 | Baird | Initiate | Outperform |
| 2024-05-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Oppenheimer | Reiterate | Outperform -> Outperform |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-15 | Leerink Partners | Initiate | Outperform |
| 2024-03-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-03-07 | Roth MKM | Maintains | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-29 | RBC Capital | Maintains | Outperform -> Outperform |
MIND MEDICINE MINDMED INC / MNMD FAQ
Can you provide the average price target for MIND MEDICINE MINDMED INC stock?
18 analysts have analysed MNMD and the average price target is 26.15 USD. This implies a price increase of 91.71% is expected in the next year compared to the current price of 13.64.
What is the consensus rating for MNMD stock?
The consensus rating for MIND MEDICINE MINDMED INC (MNMD) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.